Evidence map›Paper›PMID 36234403›Full record

ReviewNanomaterials (Basel, Switzerland)2022

Adverse Outcome Pathways Associated with the Ingestion of Titanium Dioxide Nanoparticles-A Systematic Review.

Dora Rolo, Ricardo Assunção, Célia Ventura, Paula Alvito, Lídia Gonçalves, Carla Martins, Ana Bettencourt, Peter Jordan, Nádia Vital, Joana Pereira and 4 more

Abstract readReview
In one paragraph

Review in Nanomaterials (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Dora RoloNational Institute of Health Dr. Ricardo Jorge, 1649-016 Lisbon, Portugal.
Ricardo AssunçãoNational Institute of Health Dr. Ricardo Jorge, 1649-016 Lisbon, Portugal.ORCID 0000-0002-4375-0456
Célia VenturaNational Institute of Health Dr. Ricardo Jorge, 1649-016 Lisbon, Portugal.ORCID 0000-0002-0637-2222
Paula AlvitoNational Institute of Health Dr. Ricardo Jorge, 1649-016 Lisbon, Portugal.ORCID 0000-0001-8396-1357
Lídia GonçalvesResearch Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, University of Lisbon, 1649-003 Lisbon, Portugal.ORCID 0000-0002-6799-2740
Carla MartinsNational Institute of Health Dr. Ricardo Jorge, 1649-016 Lisbon, Portugal.ORCID 0000-0001-7930-2914
Ana BettencourtResearch Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, University of Lisbon, 1649-003 Lisbon, Portugal.ORCID 0000-0002-8498-5892
Peter JordanNational Institute of Health Dr. Ricardo Jorge, 1649-016 Lisbon, Portugal.ORCID 0000-0002-1425-9211
Nádia VitalNational Institute of Health Dr. Ricardo Jorge, 1649-016 Lisbon, Portugal.
Joana PereiraNational Institute of Health Dr. Ricardo Jorge, 1649-016 Lisbon, Portugal.
Fátima PintoNational Institute of Health Dr. Ricardo Jorge, 1649-016 Lisbon, Portugal.ORCID 0000-0002-9377-4085
Paulo MatosNational Institute of Health Dr. Ricardo Jorge, 1649-016 Lisbon, Portugal.ORCID 0000-0002-9379-9696
Maria João SilvaNational Institute of Health Dr. Ricardo Jorge, 1649-016 Lisbon, Portugal.ORCID 0000-0002-6060-0716
Henriqueta LouroNational Institute of Health Dr. Ricardo Jorge, 1649-016 Lisbon, Portugal.ORCID 0000-0001-9744-7332

Funding

Fundação para a Ciência e Tecnologia 2020.07168.BDFundação para a Ciência e Tecnologia CEECIND/01570/2018Fundação para a Ciência e Tecnologia CEECIND/03143/2017Fundação para a Ciência e Tecnologia LA/P/0094/2020Fundação para a Ciência e Tecnologia PTDC/SAU-PUB/29481/2017Fundação para a Ciência e Tecnologia UIDB/00009/2020Fundação para a Ciência e Tecnologia UIDB/04138/2020Fundação para a Ciência e Tecnologia UIDB/50017/2020Fundação para a Ciência e Tecnologia UID/MULTI/04046/2019Fundação para a Ciência e Tecnologia UIDP/00009/2020Fundação para a Ciência e Tecnologia UIDP/04138/2020Fundação para a Ciência e Tecnologia UIDP/50017/2020
6 · The paper itself

Abstract

Titanium dioxide nanoparticles (TiO

Indexed as

adverse outcomesAOPcolorectal cancerhuman exposureingested TIO2-NPsnanosafetytitanium dioxide nanoparticles

Identifiers

PMID36234403
PMCPMC9565478

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.